Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T R Gadek

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Experimental Cell Research|August 1, 1995
Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actionsG Shankar, T R Gadek, D J Burdick, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedureP L Felgner, T R Gadek, M Holm, et al.
Journal of Medicinal Chemistry|May 29, 1992
Cyclic RGD peptide analogues as antiplatelet antithromboticsP L Barker, S Bullens, S Bunting, et al.
Eye (London, England)|April 28, 2012
Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b studyD M Paskowitz, Q D Nguyen, P Gehlbach, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirementsA Peyman, V Wehner, J Knolle, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 16, 2008
Preclinical absorption, distribution, metabolism and excretion (ADME) characterization of ICAM1988, an LFA-1/ICAM antagonist, and its prodrugS C Khojasteh, D D Leipold, F Lai, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2001
alpha(v)beta(3) Antagonists based on a central thiophene scaffoldA Peyman, K Scheunemann, D W Will, et al.
Circulation|February 27, 2001
Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplastyT J Chico, J Chamberlain, J Gunn, et al.
Science (New York, N.Y.)|February 9, 2002
Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small moleculeT R Gadek, D J Burdick, R S McDowell, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Experimental Cell Research|August 1, 1995
Structural determinants of calcium signaling by RGD peptides in rat osteoclasts: integrin-dependent and -independent actionsG Shankar, T R Gadek, D J Burdick, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1987
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedureP L Felgner, T R Gadek, M Holm, et al.
Journal of Medicinal Chemistry|May 29, 1992
Cyclic RGD peptide analogues as antiplatelet antithromboticsP L Barker, S Bullens, S Bunting, et al.
Eye (London, England)|April 28, 2012
Safety, tolerability, and bioavailability of topical SAR 1118, a novel antagonist of lymphocyte function-associated antigen-1: a phase 1b studyD M Paskowitz, Q D Nguyen, P Gehlbach, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2000
RGD mimetics containing a central hydantoin scaffold: alpkha(v)beta3 vs alpha(IIb)beta3 selectivity requirementsA Peyman, V Wehner, J Knolle, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 16, 2008
Preclinical absorption, distribution, metabolism and excretion (ADME) characterization of ICAM1988, an LFA-1/ICAM antagonist, and its prodrugS C Khojasteh, D D Leipold, F Lai, et al.
Bioorganic & Medicinal Chemistry Letters|July 17, 2001
alpha(v)beta(3) Antagonists based on a central thiophene scaffoldA Peyman, K Scheunemann, D W Will, et al.
Circulation|February 27, 2001
Effect of selective or combined inhibition of integrins alpha(IIb)beta(3) and alpha(v)beta(3) on thrombosis and neointima after oversized porcine coronary angioplastyT J Chico, J Chamberlain, J Gunn, et al.
Science (New York, N.Y.)|February 9, 2002
Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small moleculeT R Gadek, D J Burdick, R S McDowell, et al.
Pageof 1